Biocompatibility and security of new type nano-hydroapatite crystals and polyamide for bone reconstruction and repair after implanting in vivo

孟纯阳,安洪,蒋电明,李玉宝,魏杰

DOI: https://doi.org/10.3321/j.issn:1673-8225.2004.29.024

2004-01-01

Abstract:Aim: To investigate the acute or chronic toxic reaction on the whole body induced by the new type nano-hydroapatite crystals and polyamide composite (n-HA/PA66) for bone reconstruction and repair after implanting in vivo and its effect on partial constitution of animal organs after implanting in vivo, and evaluate the potential and degree of subcuticular stimulation reaction. Methods: According to the evaluated criteria of medical implanted materials, biology and animal trial recommended in GB/T16 886.5-1997-ISO 10 993-5: 1992, n-HA/PA66 composite was implanted into the muscle of animal and blood was drawn at different points. General and histochemical examinations of blood were performed at different points. The inflammation index, the biochemical index of blood and the functional indexes of liver and kidney were measured to evaluate the acute toxic reaction on the whole body. Diffusion solution at different concentrations was added into the sample of animal blood to measure each absorbance with spectrophotometer and work out the corresponding rate of haemolysis. The primary irritation index (PII) was worked out after observing at the rated point by subcutaneous injection into the back of animal. Results: The results showed that the n-HA/PA66 composite had no apparent inflammatory reaction in vivo. There was no obvious significance between the treatment group and control group at different period (P > 0.05). There were no obvious changes in general blood, the indexes of inflammation and biochemical blood as well as the function of liver and kidney. Pathologic tissue section showed that the peripheral packed tissue of materials and the inflammation change accorded with the general regularity of inflammatory outcome; The rate of hemolysis to different concentration diffusion solution was < 3%, under the standard criteria (5%); The PII was measured 0-0.4 after the diffusion solution was injected into the back of animal, and the stimulation reaction was very slight according to the criteria. Conclusion: The new type n-HA/PA66 composite for bone repair and reconstruction has good biocompatibility and security.